Ievgeniia Burlaka, MD, PhD has completed PhD in 2009 in National O.O. Bogomolets Medical University (Kyiv, Ukraine). In 2008-2014 worked as a researcher in Karolinska Institutet (Sweden, Stockholm) in Department of Children’s and Women’s Health in Molecular and Cellular Pediatric Laboratory. Currently works as a Professor’s Assistant in Department of Pediatrics â„–4 in National O.O. Bogomolets Medical University (Kyiv, Ukraine). Current research interest is studying of the initial molecular disorders leading to the irreversible kidney damage in patients with albuminuric kidney diseases. She has published more than 60 papers in international and local Ukrainian journals. Ievgeniia Burlaka, MD, PhD has completed PhD in 2009 in National O.O. Bogomolets Medical University (Kyiv, Ukraine). In 2008-2014 worked as a researcher in Karolinska Institutet (Sweden, Stockholm) in Department of Children’s and Women’s Health in Molecular and Cellular Pediatric Laboratory. Currently works as a Professor’s Assistant in Department of Pediatrics â„–4 in National O.O. Bogomolets Medical University (Kyiv, Ukraine). Current research interest is studying of the initial molecular disorders leading to the irreversible kidney damage in patients with albuminuric kidney diseases. She has published more than 60 papers in international and local Ukrainian journals.

Genetics and Molecular Biology